Related Experiment Video
Updated: Aug 9, 2026

05:17
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease
N K Boughton-Smith1, S M Evans, C J Hawkey
1Wellcome Research Laboratories, Beckenham, Kent, UK.
Lancet (London, England)
|August 7, 1993
Summary
Elevated nitric oxide (NO) synthase activity in the colon mucosa is linked to ulcerative colitis, but not Crohn's disease. This finding suggests a role for NO in active ulcerative colitis inflammation and potential motility issues.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- Inflammatory stimuli can induce nitric oxide (NO) synthase, leading to excessive NO production.
- Excessive NO contributes to vascular permeability changes and tissue injury.
- NO synthase activity in inflammatory bowel diseases is not fully understood.
Purpose of the Study:
- To measure and compare NO synthase activities in the colonic mucosa and muscle of patients with ulcerative colitis and Crohn's disease versus controls.
- To investigate the potential role of NO synthase induction in the pathophysiology of ulcerative colitis and Crohn's disease.
Main Methods:
- NO synthase activities were measured in colonic mucosal and muscle tissues.
- Samples were obtained from control patients, patients with ulcerative colitis, and patients with Crohn's disease.
- Statistical analysis was performed to compare enzyme activities between groups.
Main Results:
- NO synthase activity was approximately eightfold higher in the colonic mucosa of ulcerative colitis patients compared to controls (p < 0.001).
- No significant difference in NO synthase activity was observed in the colonic muscle of ulcerative colitis patients or in any tissue from Crohn's disease patients compared to controls.
- Mucosal NO synthase activity in Crohn's disease patients did not differ from control values.
Conclusions:
- The induction of colonic NO synthase in the mucosa is implicated in the mucosal vasodilation and increased vascular permeability characteristic of active ulcerative colitis.
- Elevated NO synthase activity may also contribute to the impaired motility observed in toxic dilation associated with ulcerative colitis.
Related Concept Videos
Peroxisomes
Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

